Inventor
AGRAWAL NEERAJ JAGDISH
US14 patents
⚠️ This page may combine multiple inventors who share the name “AGRAWAL NEERAJ JAGDISH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
12 patentsUS10851144B2Dec 1, 2020
Interleukin-2 muteins for the expansion of T-regulatory cells
AMGEN INC16 citations89
US11541103B2Jan 3, 2023
Interleukin-21 mutein/ anti-PD-1 antibody conjugates
AMGEN INC7 citations82
US11530274B2Dec 20, 2022
Anti-STEAP1 antigen-binding protein
AMGEN INC8 citations81
US11891435B2Feb 6, 2024
Polynucleotides encoding monoclonal antibodies binding to human pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1) and methods of making thereof
AMGEN INC1 citations71
US11248043B2Feb 15, 2022
Methods for treating a headache condition using anti-human PAC1 antibodies or antigen-binding fragments thereof
AMGEN INC1 citations71
US10738110B2Aug 11, 2020
PAC1 antibodies and uses thereof
AMGEN INC3 citations71
US11518808B2Dec 6, 2022
Anti-PD-1 antibodies and methods of treatment
AMGEN INC5 citations68
US11059908B2Jul 13, 2021
Low-viscosity antigen binding proteins and methods of making them
AMGEN INC3 citations67
US12103979B2Oct 1, 2024
N-acetylated and non-acetylated dipeptides containing arginine to reduce the viscosity of viscous compositions of therapeutic polypeptides
AMGEN INC0 citations58
US11976103B2May 7, 2024
Interleukin-2 muteins for the expansion of T-regulatory cells
AMGEN INC0 citations58
US11993663B2May 28, 2024
Low-viscosity antigen binding proteins and methods of making them
AMGEN INC0 citations57
US12516111B2Jan 6, 2026
Direct selection of cells expressing high levels of heteromeric proteins using glutamine synthetase intragenic complementation vectors
AMGEN INC0 citations50